AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
The virtual summit on the use of AI technology in Oncology
Event Date: Wed, 28 Jan 2021
Event Location: Dubai
The AI in Oncology Summit will be focusing on the practical application and potential use of Artificial Intelligence (AI) in the therapeutic area of oncology. AI can provide a competitive edge by preserving and enhancing the value of the R&D pipeline through AI-based approaches. The summit will be held in a digital format and will explore how companies could improve their clinical development performance even in times of unprecedented challenges related to COVID-19.
Speakers
Juergen Scheele
SMD Senior Medical Director
Prof. Dr. Dr. Juergen Scheele is the Global Clinical Development Lead for Tepotinib at Merck KGaA.
Andreas Penk
Adv. Board, CancerCoin
Dr. Andreas Penk is a member of the Advisory Board of CancerCoin
Oliver Eckelmann
CEO, Discoveric Bio
Oliver Eckelmann, PhD is an entrepreneur that is leading and involved in the founding of several Biotech companies.
Gunjan Bhardwaj
CEO, Innoplexus
Dr. Gunjan Bhardwaj is the Chief Executive Officer of the German Artificial Intelligence company Innoplexus AG.
Date, Schedule & Speakers
January 28, 2021, at 4 pm to 5.30 pm
| Time | Topic | Speaker |
|---|---|---|
| 16:00 – 16:10 | Introduction Greetings and a short summary of the story of and the tech behind Innoplexus |
Gunjan Bhardwaj, Innoplexus |
| 16:10 – 16:30 | Challenges in oncology drug development Learn more about how to handle opportunities and challenges in oncology drug development using a strategic approach |
Juergen Scheele, Merck |
| 16:30 – 16:50 | Revolutionizing drug discovery with AI-powered target identification Find out how the Discoveric Bio Group augments their team of researchers with AI-driven analytics |
Oliver Eckelmann, Discoveric Bio Group |
| 16:50 – 17:10 | Accelerating oncology research with blockchain CancerCoin is a new concept of using blockchain to improve the ability to bring oncology drugs safer to the market |
Andreas Penk, CancerCoin |
| 17:10 – 17:30 | Summary & closing remarks Wrap up of the summit and some sneak peeks on what next developments will happen in AI-powered oncology research |
Gunjan Bhardwaj, Innoplexus |
